Accessibility Menu
Cs Diagnostics logo

Cs Diagnostics(OTC) FZRO

Market CapN/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2005)-100%
5 Year-99%
1 Year-7%
1 Month+17%
N/A
Cs Diagnostics last closing stock price
MetricPriceDate
Last closeUSD 0.072026-08-05
Cs Diagnostics stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 0.072026-07-29
1 month+16.67%USD 0.062026-07-06
3 month-34.88%USD 0.112026-05-07
Year to date-77.12%USD 0.312025-12-31
1 year-7.47%USD 0.082025-08-05
3 year-98.6%USD 5.002023-08-02
5 year-98.63%USD 5.122021-08-06
Since inception-100%USD 1,000,000,000.002005-01-24

Cs Diagnostics Financials at a Glance

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$122.20K

Net Income (TTM)

$12.93K

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Estimated Earnings Date

N/A

FZRO News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cs Diagnostics

FlashZero Corp. is an emerging enterprise focused on providing a digital service and online community tailored for children. Through a licensing agreement with Two Dog Net, Inc., the company markets its flagship product, "The Children's Internet," which offers a controlled online environment for educational and entertaining content.

Products and Services
  • "The Children's Internet" provides access to pre-vetted, age-appropriate web pages
  • Features include email, homework support, games, and news updates
  • Specialized portals for various learning activities and educational resources
Growth Outlook
  • Recent quarterly revenue increased to $23,050, showing potential for growth
  • Strong cash position with $6,813 in cash and cash equivalents
  • Intangible assets valued at $499.4 million indicate significant market potential
Financial Highlights
  • Trailing twelve months (TTM) P/E ratio stands at 175, reflecting investor interest
  • Current ratio of 5.61 suggests strong liquidity and financial health
  • Net income for Q2 2025 was $196, indicating a positive trend
FlashZero Corp. operates in the shell companies industry and is headquartered in Houston, Texas. The company aims to create a safe online space for children, combining education with entertainment. The recent financial data indicates a growing interest in the company's offerings, as evidenced by the increase in quarterly revenue and a solid cash position. The high P/E ratio suggests that investors are optimistic about future growth, while the current ratio indicates a strong ability to meet short-term obligations. With a focus on children's digital safety and education, FlashZero Corp. is positioned to capitalize on the expanding market for online educational resources.
AI Generated • Jul 25, 2026

Industry

Healthcare Providers and Services

Sector

Health Care

CEO

Ramiro Jordan, PhD

Website

csdcorp.us

Headquarters

Houston, TX 77056, US

FZRO Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

0.01%

Return on Capital

0.01%

Return on Assets

0.01%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$98.42K

Operating Income

$12.92K

EBITDA

$13.11K

Operating Cash Flow

$64.97K

Capital Expenditure

$0.00

Free Cash Flow

$64.97K

Cash & ST Invst.

$6.81K

Total Debt

$0.00

Cs Diagnostics Performance Analysis

Cs Diagnostics annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 25,500N/A
20232023-12-31USD 126,038394.3%
20242024-12-31USD 110,911-12.0%
20252025-12-31USD 204,00083.9%
Cs Diagnostics sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-06-30-15.2%
Q22025-06-30N/A
Q32025-09-303057.5%
Q42025-12-31N/A
Cs Diagnostics annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD 0.02N/A
20232023-12-31USD -0.00N/A
20242024-12-31USD 0.00N/A
20252025-12-31USD 0.00N/A
Cs Diagnostics sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-06-30-64.7%
Q22025-06-30N/A
Q32025-09-30N/A
Q42025-12-31N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2025YOY CHG

Revenue

$23.05K

-53.5%

Gross Profit

$0.00

-100.0%

Gross Margin

0.00%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

-$182.00

+99.9%

EBITDA

$0.00

+100.0%

Quarterly Fundamentals

Name
Q3 2025YOY CHG

Total Cash

$6.81K

-61.5%

Total Debt

$0.00

N/A

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

0.01%

N/A

Return on Invested Capital

0.01%

N/A

Free Cash Flow

-$183.00

N/A

Operating Cash Flow

-$183.00

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
RGLGUHF Logistics Group, Inc.
$1.13+11.88%
CNCNChun Can Capital Group
$0.00+0.00%
DVTCDevelopment Technologies Corp.
$5.01+0.00%
TPNTFThird Point Investors Limited
$20.20+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF
$44.61+0.16%
NOKNokia
$10.40-0.04%
INTCIntel
$95.76-0.07%
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$127.27-0.16%

Questions About FZRO

What is the current price of Cs Diagnostics?

Cs Diagnostics is trading at N/A per share.

What is the 52-week range for Cs Diagnostics?

Over the past 52 weeks, Cs Diagnostics has traded between N/A and N/A.

How much debt does Cs Diagnostics have?

As of the most recent reporting period, Cs Diagnostics reported total debt of $0.00.

How much cash does Cs Diagnostics have on hand?

Cs Diagnostics reported $6.81K in cash and cash equivalents in its most recent financial results.

What is Cs Diagnostics’s dividend yield?

Cs Diagnostics does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services